Nialamide: Difference between revisions
No edit summary |
No edit summary |
||
| Line 5: | Line 5: | ||
{{CMG}} | {{CMG}} | ||
==Overview== | ==Overview== | ||
'''Nialamide''' ('''Niamid''', '''Niamide''', '''Nuredal''', '''Surgex''') is a non-selective, [[irreversible_inhibition|irreversible]] [[monoamine oxidase inhibitor]] (MAOI) of the [[hydrazine]] class that was used as an [[antidepressant]]. | '''Nialamide''' ('''Niamid''', '''Niamide''', '''Nuredal''', '''Surgex''') is a non-selective, [[irreversible_inhibition|irreversible]] [[monoamine oxidase inhibitor]] (MAOI) of the [[hydrazine]] class that was used as an [[antidepressant]]. It was withdrawn by [[Pfizer]] several decades ago due to the risk of [[hepatotoxicity]]. | ||
==References== | ==References== | ||
Revision as of 14:13, 8 April 2015
|
WikiDoc Resources for Nialamide |
|
Articles |
|---|
|
Most recent articles on Nialamide |
|
Media |
|
Evidence Based Medicine |
|
Clinical Trials |
|
Ongoing Trials on Nialamide at Clinical Trials.gov Clinical Trials on Nialamide at Google
|
|
Guidelines / Policies / Govt |
|
US National Guidelines Clearinghouse on Nialamide
|
|
Books |
|
News |
|
Commentary |
|
Definitions |
|
Patient Resources / Community |
|
Patient resources on Nialamide Discussion groups on Nialamide Directions to Hospitals Treating Nialamide Risk calculators and risk factors for Nialamide
|
|
Healthcare Provider Resources |
|
Causes & Risk Factors for Nialamide |
|
Continuing Medical Education (CME) |
|
International |
|
|
|
Business |
|
Experimental / Informatics |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]
Overview
Nialamide (Niamid, Niamide, Nuredal, Surgex) is a non-selective, irreversible monoamine oxidase inhibitor (MAOI) of the hydrazine class that was used as an antidepressant. It was withdrawn by Pfizer several decades ago due to the risk of hepatotoxicity.